Oman inaugurates advanced CPHL for disease surveillance

OMAN—The Central Public Health Laboratory (CPHL) in Oman has officially opened its doors, featuring cutting-edge facilities designed to transform the nation’s disease-monitoring and response capabilities.

The laboratory serves as the country’s primary reference centre for sophisticated testing, disease investigation, genetic analysis, and quality control across all health facilities.

The new facility directly supports critical programmes that monitor both infectious and non-infectious diseases throughout Oman.

Additionally, it oversees food safety, water quality, and environmental health while tracking the growing threat of antimicrobial resistance.

These functions make CPHL essential to protecting public health across the sultanate.

Built to meet international standards, the laboratory features advanced molecular biology equipment and gene sequencing technology.

The facility also operates intelligent information systems that enhance Oman’s ability to practice preventive medicine and deliver precise treatments.

Furthermore, these capabilities strengthen early warning systems and enable rapid responses to disease outbreaks.

Dr Ahmed bin Salim al Mandhari, Under-Secretary of the Ministry of Health for Planning and Health Regulation, called the opening a major achievement for the nation.

He emphasized that the laboratory demonstrates Oman’s dedication to health security under the leadership of His Majesty Sultan Haitham bin Tarik.

The facility aligns with Oman Vision 2040, which prioritizes quality of life and sustainable health for all citizens.

The laboratory’s importance becomes clear when examining its workload.

During 2025, Ministry of Health laboratories, including CPHL, performed approximately 22.9 million tests.

These tests enable quick identification of health threats, detection of harmful microbes, and monitoring of genetic mutations that could affect treatment effectiveness.

Beyond immediate health needs, the laboratory creates opportunities for scientific research and collaboration.

It welcomes partnerships with academic institutions both locally and internationally.

The facility trains specialized Omani professionals in laboratory sciences, positioning itself as a regional centre for innovation and knowledge sharing.

Dr Ali bin Abdulhussein al Lawati, Adviser to the Minister’s Office for Engineering Affairs, provided details about the physical scope of the project.

The laboratory occupies 53,000 square metres of land with 19,480 square metres of building space, with the total investment reached RO 18.2 million (USD$47.3 million).

The three-story facility houses high-security laboratories rated BS 2-BS and BS 3-BS for handling dangerous pathogens safely.

Specialized sections focus on virology, bacteriology, chemistry, toxicology, newborn screening, genetic sequencing, and bioinformatics.

The building includes a lecture hall, library, meeting rooms, and training laboratories to support ongoing education for health professionals.

Dr Zakaria al Balushi, Director-General of the Centre for Disease Control and Prevention, highlighted how the laboratory delivers highly efficient services.

These services contribute to early disease detection and rapid public health responses that meet both national and international standards.

The World Health Organization has accredited CPHL as a reference centre for diseases including polio and influenza.

This recognition reflects the laboratory’s role in epidemiological surveillance across Oman.

The facility maintains quality standards and advances training programmes for public health workers throughout the region.

Dr Hanan al Kindi explained the unique capabilities of the Genetic Sequencing Laboratory.

The unit analyzes how bacteria evolve and monitors drug resistance patterns.

This information directly supports treatment programmes for serious diseases such as HIV, tuberculosis, and seasonal influenza.

Dr Amina al Jardani, Senior Consultant Physician, emphasized the laboratory’s regional importance. CPHL serves as a leading reference centre in the Eastern Mediterranean region.

The facility undertakes WHO-accredited regional responsibilities for influenza, polio, measles, and rubella surveillance.

It also participates in the PulseNet Middle East network, which tracks foodborne disease outbreaks.

The laboratory sets quality assurance standards for microbiology throughout the region.

WHO has designated it as a Collaborating Centre for Emerging Diseases, recognizing its expertise in identifying and responding to new health threats.

Through precision testing, protective measures, and progressive capabilities, the Central Public Health Laboratory strengthens health security for Oman and the broader region.